OBJECTIVE: The objective of this study was to investigate correlation of the changes in serum levels of cholesterol (chol), lipoprotein (a) (Lpa) and homocysteine (HCY) with incident cerebral infarction and cerebral hemorrhage. METHODS: Data on a total of 418 patients (318 cerebral infarction events and 100 cerebral hemorrhage cases) were analyzed in this study. Serum chol and HCY levels were tested by means of GPO-PAP. Serum Lpa levels were measured using latex agglutination turbidimetry. RESULTS: Patients with cerebral infarction showed significantly higher serum Lpa levels and anomaly ratio than those with cerebral hemorrhage (P<0.05), while no significant changes were identified for chol and HCY (P>0.05). Analyses by age indicated substantially increased Lpa concentration among cerebral infarction patients>60 years of age (P<0.05). No statistical significance was observed in other analyses carried out in the study. CONCLUSION: These results demonstrate that Lpa concentration is clearly correlated with cerebral infarction incidence. Lpa may act as an independent risk factor and could be used as a biomarker for this disease.
OBJECTIVE: The objective of this study was to investigate correlation of the changes in serum levels of cholesterol (chol), lipoprotein (a) (Lpa) and homocysteine (HCY) with incident cerebral infarction and cerebral hemorrhage. METHODS: Data on a total of 418 patients (318 cerebral infarction events and 100 cerebral hemorrhage cases) were analyzed in this study. Serum chol and HCY levels were tested by means of GPO-PAP. Serum Lpa levels were measured using latex agglutination turbidimetry. RESULTS:Patients with cerebral infarction showed significantly higher serum Lpa levels and anomaly ratio than those with cerebral hemorrhage (P<0.05), while no significant changes were identified for chol and HCY (P>0.05). Analyses by age indicated substantially increased Lpa concentration among cerebral infarctionpatients>60 years of age (P<0.05). No statistical significance was observed in other analyses carried out in the study. CONCLUSION: These results demonstrate that Lpa concentration is clearly correlated with cerebral infarction incidence. Lpa may act as an independent risk factor and could be used as a biomarker for this disease.
Authors: Martin Greif; Thomas Arnoldt; Franz von Ziegler; Janine Ruemmler; Christoph Becker; Reza Wakili; Melvin D'Anastasi; Jan Schenzle; Alexander W Leber; Alexander Becker Journal: Eur J Intern Med Date: 2012-09-27 Impact factor: 4.487
Authors: Vincent J Carey; Louise Bishop; Nancy Laranjo; Benjamin J Harshfield; Carolyn Kwiat; Frank M Sacks Journal: Am J Cardiol Date: 2010-08-01 Impact factor: 2.778
Authors: Alon Schaffer; Monica Verdoia; Ettore Cassetti; Paolo Marino; Harry Suryapranata; Giuseppe De Luca Journal: Thromb Res Date: 2014-05-27 Impact factor: 3.944
Authors: Satu Mustanoja; Daniel Strbian; Jukka Putaala; Atte Meretoja; Sami Curtze; Elena Haapaniemi; Tiina Sairanen; Ronja Hietikko; Joonas Sirén; Markku Kaste; Turgut Tatlisumak Journal: Stroke Date: 2013-06-11 Impact factor: 7.914
Authors: Samuel Henrique Vieira Oliveira; Marciano Robson de Miranda; Charles Augusto Santos Morais; András Palotás; Luciana Moreira Lima Journal: Brain Res Bull Date: 2013-05-28 Impact factor: 4.077